The FDA’s Oncologic Drugs Advisory Committee voted in support of approving pembrolizumab for the treatment of patients with Bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in-situ with or without papillary tumors who are ineligible for or chose to not undergo cystectomy.
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published…
People who watch at least five hours of TV a day are found to be more likely to need to wake up and urinate at…
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published…
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published…
The Journal of Pathology: Clinical Research, official OA Journal for the Pathological Society, publishes both basic biomedical science and clinical medicine research.
Bacillus Calmette-Guérin (BCG) is the standard of care for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT). BCG in…
The long-awaited inaugural episode of the European Urology Oncology (EUO) podcast is here! Host, Dr Renu Eapen (Melbourne) highlights two key papers from the December…
The long-awaited inaugural episode of the European Urology Oncology (EUO) podcast is here! Host, Dr Renu Eapen (Melbourne) highlights two key papers from the December…
Posted 9:21:53 PM. The University of Sheffield is recruiting high-performing cancer research leaders to join us to…See this and similar jobs on LinkedIn.
We are looking to appoint 5 or more academics and clinical academics into a range of roles including professorial
